Fuentes JA - Search Results

1

Antidepressant-like effects of CCK(B) receptor antagonists: involvement of the opioid system.

Hernando F, Fuentes JA, Fournié-Zaluski MC, Roques BP, Ruiz-Gayo M. Hernando F, et al. Among authors: fuentes ja. Eur J Pharmacol. 1996 Dec 30;318(2-3):221-9. doi: 10.1016/s0014-2999(96)00773-x. Eur J Pharmacol. 1996. PMID: 9016909

2

The CCKB receptor antagonist, L-365,260, elicits antidepressant-type effects in the forced-swim test in mice.

Hernando F, Fuentes JA, Roques BP, Ruiz-Gayo M. Hernando F, et al. Among authors: fuentes ja. Eur J Pharmacol. 1994 Aug 22;261(3):257-63. doi: 10.1016/0014-2999(94)90115-5. Eur J Pharmacol. 1994. PMID: 7813546

3

Impairment of stress adaptive behaviours in rats by the CCKA receptor antagonist, devazepide.

Hernando F, Fuentes JA, Ruiz-Gayo M. Hernando F, et al. Among authors: fuentes ja. Br J Pharmacol. 1996 May;118(2):400-6. doi: 10.1111/j.1476-5381.1996.tb15416.x. Br J Pharmacol. 1996. PMID: 8735644 Free PMC article.

4

A role for central cannabinoid and opioid systems in peripheral delta 9-tetrahydrocannabinol-induced analgesia in mice.

Reche I, Fuentes JA, Ruiz-Gayo M. Reche I, et al. Among authors: fuentes ja. Eur J Pharmacol. 1996 Apr 22;301(1-3):75-81. doi: 10.1016/0014-2999(96)00045-3. Eur J Pharmacol. 1996. PMID: 8773449

5

Potentiation of delta 9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of mu- and kappa-opioid receptors.

Reche I, Fuentes JA, Ruiz-Gayo M. Reche I, et al. Among authors: fuentes ja. Eur J Pharmacol. 1996 Dec 27;318(1):11-6. doi: 10.1016/s0014-2999(96)00752-2. Eur J Pharmacol. 1996. PMID: 9007506

6

Inhibition of the hypothalamic-pituitary-adrenal axis in food-deprived rats by a CCK-A receptor antagonist.

Ruiz-Gayo M, Garrido MM, Fuentes JA. Ruiz-Gayo M, et al. Among authors: fuentes ja. Br J Pharmacol. 2000 Mar;129(5):839-42. doi: 10.1038/sj.bjp.0703117. Br J Pharmacol. 2000. PMID: 10696079 Free PMC article.

7

Inhibition of opioid-degrading enzymes potentiates delta9-tetrahydrocannabinol-induced antinociception in mice.

Reche I, Ruiz-Gayo M, Fuentes JA. Reche I, et al. Among authors: fuentes ja. Neuropharmacology. 1998;37(2):215-22. doi: 10.1016/s0028-3908(98)00005-7. Neuropharmacology. 1998. PMID: 9680246

8

Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine.

Vela G, Ruiz-Gayo M, Fuentes JA. Vela G, et al. Among authors: fuentes ja. Neuropharmacology. 1995 Jun;34(6):665-8. doi: 10.1016/0028-3908(95)00032-2. Neuropharmacology. 1995. PMID: 7566503

9

Cannabinoids as potential new analgesics.

Fuentes JA, Ruiz-Gayo M, Manzanares J, Vela G, Reche I, Corchero J. Fuentes JA, et al. Life Sci. 1999;65(6-7):675-85. doi: 10.1016/s0024-3205(99)00290-8. Life Sci. 1999. PMID: 10462068 Review.

10

Perinatal exposure to delta 9-tetrahydrocannabinol (delta 9-THC) leads to changes in opioid-related behavioral patterns in rats.

Vela G, Fuentes JA, Bonnin A, Fernández-Ruiz J, Ruiz-Gayo M. Vela G, et al. Among authors: fuentes ja. Brain Res. 1995 May 22;680(1-2):142-7. doi: 10.1016/0006-8993(95)00255-o. Brain Res. 1995. PMID: 7663970

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters